International Myopia Institute appoints new chief scientist
The International Myopia Institute (IMI) has appointed the UK’s Professor James Wolffsohn as its chief scientist, following the retirement of ...
The International Myopia Institute (IMI) has appointed the UK’s Professor James Wolffsohn as its chief scientist, following the retirement of ...
Eyecare professionals are being urged to remain abreast of the most current myopia management methods as Australian not-for-profit the Brien ...
Three Australian academics in a group of global myopia experts have contributed to a collection of white papers presenting the ...
Bausch + Lomb has acquired an exclusive license for a novel myopia control contact lens developed by a Sydney ophthalmic ...
The International Myopia Institute (IMI) has launched a global search for country representatives to lead the dissemination of key information ...
Australian agencies are collaborating with technology firm Big Picture Medical in a $12 million project to develop an AI-assisted platform ...
Epidemiological studies and clinical trials involving optical devices for myopia will be the focus of a new three-year agreement between ...
The Brien Holden Vision Institute (BHVI) has signed an agreement with global fundraising initiative Optometry Giving Sight USA (OGS) that ...
The Brien Holden Vision Institute (BHVI) has signed a licensing agreement that will see its algorithms for tracking and estimating ...
International charity Optometry Giving Sight (OGS) has announced a new board of directors who will steer the organisation towards new ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited